FSD PHARMA INC CLASS B
NASDAQ: HUGE (FSD Pharma Inc.)
Last update: 15 hours ago1.11
0.01 (1.38%)
| Previous Close | 1.09 |
| Open | 1.07 |
| Volume | 62,203 |
| Avg. Volume (3M) | 122,644 |
| Market Cap | 44,285,528 |
| Price / Sales | 91.86 |
| Price / Book | 0.480 |
| 52 Weeks Range | |
| Earnings Date | 10 Aug 2023 - 14 Aug 2023 |
| Diluted EPS (TTM) | -16.25 |
| Total Debt/Equity (MRQ) | 6.13% |
| Current Ratio (MRQ) | 1.99 |
| Return on Assets (TTM) | -36.47% |
| Return on Equity (TTM) | -63.89% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Bullish | |
| Stock | FSD Pharma Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -0.21 |
|
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 9.74% |
| % Held by Institutions | 2.69% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |